Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FT218 and divalproex sodium ER drug-drug interaction study in healthy volunteers
NL-OMON46476Active, not recruiting
- Sponsor
- Avadel Pharmaceuticals
- Start
- Mar 2018
- Modality
- Small Molecules, Cell Therapies, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of AV001 and divalproex sodium in narcolepsy, sponsored by Avadel Pharmaceuticals. Primary endpoint: Pharmacokinetics of FT218 with and without divalproex sodium ER. Started Mar 2018; status: active, not recruiting.
02
Drugs
AV001divalproex sodium
03
Conditions
narcolepsy
Beyond the preview
Go deeper on NL-OMON46476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46476.